APT Medical Inc. APT Medical Inc.

APT Medical Inc.

688617

Rang in aandelen #3231
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Aandeelprijs
$38.62
Marktkapitalisatie
$5.47B
Verandering (1 dag)
0.19%
Verandering (1 jaar)
-17.07%
Land
CN
Handel APT Medical Inc. (688617)

Categorie

Healthcare
Winst voor APT Medical Inc. (688617)
Winst in Jun 2026 TTM: $158.75M
Volgens de meest recente financiële verslagen van APT Medical Inc. bedraagt de huidige winst van het bedrijf $158.75M. In 2024 behaalde het bedrijf een winst van $102.20M, een stijging ten opzichte van de winst van 2023, die $84.25M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van APT Medical Inc. van 2017 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $158.75M 18.63%
2025 $133.82M 30.94%
2024 $102.20M 21.31%
2023 $84.25M 47.08%
2022 $57.28M 64.33%
2021 $34.86M 87.86%
2020 $18.55M 41.43%
2019 $13.12M 288.78%
2018 $3.37M -29.16%
2017 $4.76M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$6.56B 4,033.47%
US
$6.60B 4,059.29%
IE
$5.15B 3,142.78%
US
$3.86B 2,332.08%
US
$3.25B 1,947.21%
DE